{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:08:42Z","timestamp":1761718122425},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T00:00:00Z","timestamp":1259798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00280-009-1184-5","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T14:59:17Z","timestamp":1259765957000},"page":"485-491","source":"Crossref","is-referenced-by-count":42,"title":["DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"66","author":[{"given":"Rikke L.","family":"Hedeland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Hvidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Nersting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Rosth\u00f8j","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Dalhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte","family":"Lausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,3]]},"reference":[{"key":"1184_CR1","first-page":"138","volume-title":"Cancer in children","author":"K Schmiegelow","year":"2005","unstructured":"Schmiegelow K, Gustafsson G (2005) Acute lymphoblastic leukemia. In: Caron M (ed) Cancer in children. Oxford University Press, Oxford, pp 138\u2013170"},{"key":"1184_CR2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00043426-199024000-00010","volume":"12","author":"K Schmiegelow","year":"1990","unstructured":"Schmiegelow K, Pulczynska MK (1990) Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts? Am J Pediatr Hematol Oncol 12:462\u2013467","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"1184_CR3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.leu.2403783","volume":"19","author":"M Arico","year":"2005","unstructured":"Arico M, Baruchel A, Bertrand Y, Biondi A, Conter V, Eden T, Gadner H, Gaynon P, Horibe K, Hunger SP, Janka-Schaub G, Masera G, Nachman J, Pieters R, Schrappe M, Schmiegelow K, Valsecchi MG, Pui CH (2005) The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29\u201330, 2005. Leukemia 19:1145\u20131152","journal-title":"Leukemia"},{"key":"1184_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0006-2952(97)00200-1","volume":"54","author":"S Uribe-Luna","year":"1997","unstructured":"Uribe-Luna S, Quintana-Hau JD, Maldonado-Rodriguez R, Espinosa-Lara M, Beattie KL, Farquhar D, Nelson JA (1997) Mutagenic consequences of the incorporation of 6-thioguanine into DNA. Biochem Pharmacol 54:419\u2013424","journal-title":"Biochem Pharmacol"},{"key":"1184_CR5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0006-2952(93)90045-X","volume":"45","author":"JP Bokkerink","year":"1993","unstructured":"Bokkerink JP, Stet EH, De Abreu RA, Damen FJ, Hulscher TW, Bakker MA, van Baal JA (1993) 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol 45:1455\u20131463","journal-title":"Biochem Pharmacol"},{"key":"1184_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2008.316","volume":"23","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K, Forestier E, Kristinsson J, Soderhall S, Vettenranta K, Weinshilboum R, Wesenberg F (2009) Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia 23:557\u2013564","journal-title":"Leukemia"},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1209372","volume":"25","author":"L Wang","year":"2006","unstructured":"Wang L, Weinshilboum R (2006) Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Oncogene 25:1629\u20131638","journal-title":"Oncogene"},{"key":"1184_CR8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(94)92400-7","volume":"343","author":"JS Lilleyman","year":"1994","unstructured":"Lilleyman JS, Lennard L (1994) Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 343:1188\u20131190","journal-title":"Lancet"},{"key":"1184_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002800050816","volume":"42","author":"N Erb","year":"1998","unstructured":"Erb N, Harms DO, Janka-Schaub G (1998) Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine. Cancer Chemother Pharmacol 42:266\u2013272","journal-title":"Cancer Chemother Pharmacol"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","volume":"93","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93:2817\u20132823","journal-title":"Blood"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1200\/JCO.1995.13.2.345","volume":"13","author":"K Schmiegelow","year":"1995","unstructured":"Schmiegelow K, Schroder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T, Wranne L (1995) Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. J Clin Oncol 13:345\u2013351","journal-title":"J Clin Oncol"},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2125.2001.00366.x","volume":"52","author":"L Lennard","year":"2001","unstructured":"Lennard L (2001) Therapeutic drug monitoring of cytotoxic drugs. Br J Clin Pharmacol 52:75\u201387","journal-title":"Br J Clin Pharmacol"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.leu.2401961","volume":"14","author":"G Gustafsson","year":"2000","unstructured":"Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 14:2267\u20132275","journal-title":"Leukemia"},{"key":"1184_CR14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215","journal-title":"Nucleic Acids Res"},{"key":"1184_CR15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/00365518909091557","volume":"49","author":"I Bruunshuus","year":"1989","unstructured":"Bruunshuus I, Schmiegelow K (1989) Analysis of 6-mercaptopurine, 6-thioguanine nucleotides, and 6-thiouric acid in biological fluids by high-performance liquid chromatography. Scand J Clin Lab Invest 49:779\u2013784","journal-title":"Scand J Clin Lab Invest"},{"key":"1184_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0378-4347(91)80441-E","volume":"571","author":"GR Erdmann","year":"1991","unstructured":"Erdmann GR, Steury JC, Carleton BC, Stafford RJ, Bostrom BC, Canafax DM (1991) Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguanine in humans. J Chromatogr 571:149\u2013156","journal-title":"J Chromatogr"},{"key":"1184_CR17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0003-2697(76)80047-4","volume":"70","author":"BA Kamen","year":"1976","unstructured":"Kamen BA, Takach PL, Vatev R, Caston JD (1976) A rapid, radiochemical-ligand binding assay for methotrexate. Anal Biochem 70:54\u201363","journal-title":"Anal Biochem"},{"key":"1184_CR18","volume-title":"Non-parametric statistics for the behavioral science","author":"S Siegel","year":"1988","unstructured":"Siegel S, Castellan NJ (1988) Non-parametric statistics for the behavioral science. McGraw-Hill, Singapore"},{"key":"1184_CR19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/01621459.1988.10478639","volume":"83","author":"WS Cleveland","year":"1988","unstructured":"Cleveland WS, Devlin SJ (1988) Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc 83:596\u2013610","journal-title":"J Am Stat Assoc"},{"key":"1184_CR20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/clpt.1988.25","volume":"43","author":"M Peeters","year":"1988","unstructured":"Peeters M, Koren G, Jakubovicz D, Zipursky A (1988) Physician compliance and relapse rates of acute lymphoblastic leukemia in children. Clin.Pharmacol Ther 43:228\u2013232","journal-title":"Clin.Pharmacol Ther"},{"key":"1184_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/adc.76.4.365","volume":"76","author":"D Lancaster","year":"1997","unstructured":"Lancaster D, Lennard L, Lilleyman JS (1997) Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child 76:365\u2013366","journal-title":"Arch Dis Child"},{"key":"1184_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","volume":"46","author":"L Lennard","year":"1989","unstructured":"Lennard L, Van Loon JA, Weinshilboum RM (1989) Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 46:149\u2013154","journal-title":"Clin Pharmacol Ther"},{"key":"1184_CR23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","volume":"91","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui CH, Evans WE (1999) Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 91:2001\u20132008","journal-title":"J Natl Cancer Inst"},{"key":"1184_CR24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1542-3565(04)00127-2","volume":"2","author":"C Cuffari","year":"2004","unstructured":"Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM (2004) Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol 2:410\u2013417","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1184_CR25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1200\/JCO.2003.04.039","volume":"21","author":"K Schmiegelow","year":"2003","unstructured":"Schmiegelow K, Bjork O, Glomstein A, Gustafsson G, Keiding N, Kristinsson J, Makipernaa A, Rosthoj S, Szumlanski C, Sorensen TM, Weinshilboum R (2003) Intensification of mercaptopurine\/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia. J Clin Oncol 21:1332\u20131339","journal-title":"J Clin Oncol"},{"key":"1184_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","volume":"6","author":"EY Krynetski","year":"1996","unstructured":"Krynetski EY, Tai HL, Yates CR, Fessing MY, Loennechen T, Schuetz JD, Relling MV, Evans WE (1996) Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 6:279\u2013290","journal-title":"Pharmacogenetics"},{"key":"1184_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/08035259850158001","volume":"87","author":"JB Andersen","year":"1998","unstructured":"Andersen JB, Szumlanski C, Weinshilboum RM, Schmiegelow K (1998) Pharmacokinetics, dose adjustments, and 6-mercaptopurine\/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency. Acta Paediatr 87:108\u2013111","journal-title":"Acta Paediatr"},{"key":"1184_CR28","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5","volume":"86","author":"J Bo","year":"1999","unstructured":"Bo J, Schroder H, Kristinsson J, Madsen B, Szumlanski C, Weinshilboum R, Andersen JB, Schmiegelow K (1999) Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer 86:1080\u20131086","journal-title":"Cancer"},{"key":"1184_CR29","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1182\/blood-2008-11-187880","volume":"113","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, Heyman M, Kristinsson J, Nersting J, Nygaard R, Svendsen AL, Vettenranta K, Weinshilboum R (2009) Methotrexate\/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood 113:6077\u20136084","journal-title":"Blood"},{"key":"1184_CR30","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2002-08-2372","volume":"102","author":"DO Harms","year":"2003","unstructured":"Harms DO, Gobel U, Spaar HJ, Graubner UB, Jorch N, Gutjahr P, Janka-Schaub GE (2003) Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood 102:2736\u20132740","journal-title":"Blood"},{"key":"1184_CR31","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","volume":"368","author":"A Vora","year":"2006","unstructured":"Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J, Richards SM (2006) Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 368:1339\u20131348","journal-title":"Lancet"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-1184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-009-1184-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-1184-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T01:07:49Z","timestamp":1590282469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-009-1184-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s00280-009-1184-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,3]]}}}